DK296290D0 - Mellemprodukter til brug ved fremstilling af pyrimido(4,5-g)quinolin-derivater eller salte deraf - Google Patents

Mellemprodukter til brug ved fremstilling af pyrimido(4,5-g)quinolin-derivater eller salte deraf

Info

Publication number
DK296290D0
DK296290D0 DK296290A DK296290A DK296290D0 DK 296290 D0 DK296290 D0 DK 296290D0 DK 296290 A DK296290 A DK 296290A DK 296290 A DK296290 A DK 296290A DK 296290 D0 DK296290 D0 DK 296290D0
Authority
DK
Denmark
Prior art keywords
pyrimido
intermediates
salts
preparation
quinoline derivatives
Prior art date
Application number
DK296290A
Other languages
English (en)
Other versions
DK169970B1 (da
DK296290A (da
Inventor
Cynthia Lynn Nichols
Edmund Carl Kornfield
Mark Mortensen Foreman
John Mehnert Schaus
Diane Lynn Huser
Richart Nolan Booher
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/535,474 external-priority patent/US4521421A/en
Priority claimed from US06/535,503 external-priority patent/US4501890A/en
Priority claimed from US06/575,126 external-priority patent/US4528290A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK296290D0 publication Critical patent/DK296290D0/da
Publication of DK296290A publication Critical patent/DK296290A/da
Application granted granted Critical
Publication of DK169970B1 publication Critical patent/DK169970B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK296290A 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf DK169970B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US53551983A 1983-09-26 1983-09-26
US06/535,474 US4521421A (en) 1983-09-26 1983-09-26 Treatment of sexual dysfunction
US53547483 1983-09-26
US06/535,503 US4501890A (en) 1983-09-26 1983-09-26 Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
US53551983 1983-09-26
US53550383 1983-09-26
US06/575,126 US4528290A (en) 1984-01-30 1984-01-30 Stimulating dopamine D-1 receptors
US57512684 1984-01-30
US60609184A 1984-05-02 1984-05-02
US60609184 1984-05-02

Publications (3)

Publication Number Publication Date
DK296290D0 true DK296290D0 (da) 1990-12-13
DK296290A DK296290A (da) 1990-12-13
DK169970B1 DK169970B1 (da) 1995-04-18

Family

ID=27541855

Family Applications (4)

Application Number Title Priority Date Filing Date
DK400984A DK164867C (da) 1983-09-26 1984-08-22 Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse
DK296190A DK169622B1 (da) 1983-09-26 1990-12-13 Trans-(+)-stereoisomere af pyrimido[4,5-g]quinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende sådanne forbindelser
DK296290A DK169970B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf
DK296390A DK169948B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK400984A DK164867C (da) 1983-09-26 1984-08-22 Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse
DK296190A DK169622B1 (da) 1983-09-26 1990-12-13 Trans-(+)-stereoisomere af pyrimido[4,5-g]quinolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske formuleringer indeholdende sådanne forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK296390A DK169948B1 (da) 1983-09-26 1990-12-13 Mellemprodukter til brug ved fremstilling af pyrimido[4,5-g]quinolin-derivater eller salte deraf

Country Status (16)

Country Link
EP (1) EP0139393B1 (da)
JP (1) JPH01151581A (da)
AU (2) AU569539B2 (da)
CY (1) CY1495A (da)
DE (1) DE3484583D1 (da)
DK (4) DK164867C (da)
FI (1) FI78091C (da)
GB (1) GB2146985B (da)
GR (1) GR80201B (da)
HK (1) HK98789A (da)
IE (1) IE57848B1 (da)
IL (1) IL72730A (da)
NZ (1) NZ209295A (da)
PT (1) PT79112B (da)
RO (1) RO89126A (da)
SG (1) SG46389G (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR870000623B1 (ko) * 1984-08-03 1987-03-26 일라이 릴리 앤드 캄파니 트리사이클릭 퀴놀린 유도체의 제조방법
US4764609A (en) * 1986-03-31 1988-08-16 Eli Lilly And Company Synthesis of 2-aminopyrimido[4,5-g]quinolines
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
JPS59202892A (ja) * 1983-05-04 1984-11-16 Ricoh Co Ltd 光学的情報記録媒体
US4507478A (en) * 1983-09-26 1985-03-26 Eli Lilly And Company 2-Mercaptopyrimidohexahydroquinolines and related compounds
KR870000623B1 (ko) * 1984-08-03 1987-03-26 일라이 릴리 앤드 캄파니 트리사이클릭 퀴놀린 유도체의 제조방법

Also Published As

Publication number Publication date
DK400984D0 (da) 1984-08-22
FI843282A (fi) 1985-03-27
AU3228084A (en) 1985-04-04
DK169970B1 (da) 1995-04-18
DK296390D0 (da) 1990-12-13
RO89126A (ro) 1986-04-30
FI843282A0 (fi) 1984-08-20
GB8421160D0 (en) 1984-09-26
CY1495A (en) 1990-02-16
IE57848B1 (en) 1993-04-21
DK164867C (da) 1993-11-08
GB2146985B (en) 1987-05-28
FI78091C (fi) 1989-06-12
DK164867B (da) 1992-08-31
EP0139393B1 (en) 1991-05-15
IL72730A (en) 1987-10-30
JPH0529398B2 (da) 1993-04-30
NZ209295A (en) 1987-05-29
DK296190A (da) 1990-12-13
EP0139393A3 (en) 1988-01-13
GR80201B (en) 1985-01-02
AU569539B2 (en) 1988-02-04
DK296290A (da) 1990-12-13
IL72730A0 (en) 1984-11-30
DK169948B1 (da) 1995-04-10
EP0139393A2 (en) 1985-05-02
IE842154L (en) 1985-03-26
DK169622B1 (da) 1994-12-27
HK98789A (en) 1989-12-22
PT79112B (en) 1986-11-14
DK400984A (da) 1985-03-27
SG46389G (en) 1989-12-22
GB2146985A (en) 1985-05-01
DE3484583D1 (de) 1991-06-20
DK296390A (da) 1990-12-13
PT79112A (en) 1984-09-01
DK296190D0 (da) 1990-12-13
JPH01151581A (ja) 1989-06-14
AU585473B2 (en) 1989-06-15
AU8216887A (en) 1988-03-31
FI78091B (fi) 1989-02-28

Similar Documents

Publication Publication Date Title
ES522141A0 (es) Procedimiento para la preparacion de derivados de quinolina.
ES519851A0 (es) Procedimiento para la preparacion de derivados de quinolina.
DK493083A (da) Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK184588D0 (da) Mellemprodukter til brug ved fremstilling af 1alfa,25-dihydroxylerede vitamin d2-derivater
DK130382A (da) Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf
DK118482A (da) Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf
ES546506A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
DK277682A (da) Fremgangsmaade til fremstilling af substituerede imidazo (1,5-a)pyridiner eller salte deraf
ES534259A0 (es) Procedimiento para preparar nuevos derivados de imidazo (1,5-a) pirimidina
DK15390A (da) Cholestadienderivat som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK296290D0 (da) Mellemprodukter til brug ved fremstilling af pyrimido(4,5-g)quinolin-derivater eller salte deraf
MX161035A (es) Procedimiento para la preparacion de imidazo(1,2-a)quinolinas
ES499691A0 (es) Procedimiento para la preparacion de derivados de 5,11-dihi-dro-6h-pirido(2,3-b)(1,4)-benzodiazepin-6-ona
MX159288A (es) Procedimiento para la preparacion de derivados de 3,7-diazabisiclo(3,3-1)nonano
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
IT1193604B (it) 1,3,4-tiadiazolo (3,2-a) pirimidine sostituite e procedimento per la loro preparazione
AR229174A1 (es) Procedimiento para la preparacion de nuevas 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK476082A (da) Fremgangsmaade til fremstilling af phenolderivater eller salte deraf
DK162394C (da) 26-homocholesta-5-en forbindelse, der kan anvendes som mellemprodukt til brug ved fremstillingen af 26-homovitamin d3 derivater
AR227683A1 (es) Procedimiento para la preparacion de derivados de 6,7,8,9-tetrahidro-5h-pirazino(2,3-d)azepina,5,6,7,8-tetrahidro-pirido(3,4-b)pirazina y 6,7-dihidro-5h-pirrolo(3,4-b)pirazina
ES528662A0 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
ES536305A0 (es) Procedimiento para la preparacion de derivados de sulfenamida
DK186283D0 (da) Fremgangsmade til fremstilling af imidazoquinoxaliner eller salte deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed